名医汇-轻松看名医

公立三甲医院医生挂号抢号、医生咨询

Description

全国医院预约挂号网平台。患友不仅可以在名医汇免费预约全国范围内的号源,根据名医排行榜,选择适合自己的医生;还可以进行在线咨询医生、电话咨询医生、诊后就医分享、预约陪诊服务等。
目前,名医汇已覆盖全国7000多家公立医院,80多万医生,覆盖全国34个省份,100多个核心城市,近百万患友进行了体验分享。核心服务有预约预约挂号、在线图文咨询、电话咨询、名医面诊,助您轻松看名医。
1、名医排行榜:
百万患友诊后分享点评,打造名医排行榜。患友可依据“按疾病找”、“按科室找”等导航,查看相关医院及科室排行榜,精准查找适合自己的医生/医院。
2、预约挂号:
全国范围内34个省份3000多家医院号源,异地就医也能轻松实现提前预约。
3、专家在线:
在线发布自己的问题,13万+三甲公立医院坐诊的医生实时在线,3分钟极速回复,也可以协助解答你的疾病困扰!同时您也可以选择指定专家咨询,通过文字、病情图片、语音实时在线沟通!
4、电话咨询:
北京、上海、广州等全国各地近3万名知名专家,在线预约即可一对一与名医进行电话沟通。当天与医生通话成功率高达90%
5、全渠道覆盖:
名医汇汇集60多家挂号平台号源资源,一次查询相当于同时搜索多家平台号源,号源更广、预约更快捷!
6、诊后分享与点评:
诊前,查看同病患友心得分享,协助选择好医生、好医院;诊后,分享自我经验,撰写真实评价,为更多同病患友提供可靠的参考依据。

联系方式:
官网:http://www.mingyihui.net/
官方微信:“mingyihuinet”
官方邮箱:[email protected]
Hide Show More...

名医汇-轻松看名医 FAQ

  • Is 名医汇-轻松看名医 free?

    Yes, 名医汇-轻松看名医 is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is 名医汇-轻松看名医 legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does 名医汇-轻松看名医 cost?

    名医汇-轻松看名医 is free.

  • What is 名医汇-轻松看名医 revenue?

    To get estimated revenue of 名医汇-轻松看名医 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Mexico yet.
Ratings History

名医汇-轻松看名医 Reviews

No Reviews in Mexico
App doesn't have any reviews in Mexico yet.

名医汇-轻松看名医 Installs

Last 30 days

名医汇-轻松看名医 Revenue

Last 30 days

名医汇-轻松看名医 Revenue and Downloads

Gain valuable insights into 名医汇-轻松看名医 performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Languages
Chinese
Recent release
4.5.0 (3 years ago )
Released on
Sep 21, 2016 (8 years ago )
Last Updated
2 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.